3Biotech is a fully independent drug development focused company operating throughout Europe. Our premium service package is dedicated to supporting biotech startups in building a comprehensive Chemistry Manufacturing and Control (CMC) strategy for their drug development. We understand that CMC is a critical aspect of the drug development process, often underestimated but with the potential to make or break a project.

Established in 2014 by our founder and CEO, Olivier Favre-Bulle, who has extensive experience in the pharma industry, 3Biotech was created to provide impeccable CMC operations and regulatory support. We have witnessed the challenges faced by biotech companies in executing their drug development chain, hindering their innovative therapies from reaching patients in need. Our approach focuses on three major pillars: Safety, Efficacy, and Manufacturability.

We pride ourselves on being an accelerator rather than a consultancy firm, working closely with our clients as part of their team to ensure high-quality standards and performance. From drug candidate discovery to clinical proof of concept, we are here to challenge and support health tech entrepreneurs. Our clients include leading companies in the pharmaceutical industry and health investment funds, and we have achieved an impressive 96% customer satisfaction rate.

Let us be your best support on the field, guiding you from science to first-in-human trials. Contact us today to learn more about how 3Biotech can help bring your innovative therapies to market